Dupilumab Simplifies Pediatric EoE Therapy
Summary
At 12 months, the antibody alone has been used to treat 81% of patients with eosinophilic esophagitis.
Description from Medscape.
Who is covering this
-
Dupilumab Simplifies Pediatric EoE Therapy
At 12 months, the antibody alone has been used to treat 81% of patients with eosinophilic esophagitis.
Comments
Comments need JavaScript.